Release Date: 04/02/22 15:43 Summary: Units on Issue Disclosure - Jan 2022 Price Sensitive: No Download Document 115.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%